Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8 ⁺ T Cell Immunity

Judith E. Epstein, Kavita Tewari, Kirsten E. Lyke, +31

Science

MalariaImmunologyImmune RegulationImmunodominanceSuch Protection +18

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial

Charmagne Beckett, Jeffrey Tjaden, Timothy Burgess, +8

Vaccine

VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology +6

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

Ilin Chuang, Martha Sedegah, Susan Cicatelli, +43

PLoS ONE

First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers

Michele Spring, Jittawadee Murphy, Robin Nielsen, +25

Vaccine

EntomologyMalariaParasite ControlParasite GenomicsVector-parasite Relationship +7

<i>Rickettsia parkeri</i>Infection after Tick Bite, Virginia

Timothy J. Whitman, Allen L. Richards, Christopher D. Paddock, +5

Emerging infectious diseases

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component

Cindy Tamminga, Martha Sedegah, David P. Regis, +39

PLoS ONE

Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort

Stephanie K. Brodine, Monica J. Starkey, Richard A. Shaffer, +10

AIDS

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults

Martha Sedegah, Cindy Tamminga, Shannon McGrath, +31

PLoS ONE

Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes

Martha Sedegah, Michael R. Hollingdale, Fouzia Farooq, +17

PLoS ONE

Long‐Term Efficacy of Routine Access to Antiretroviral‐Resistance Testing in HIV Type 1–Infected Patients: Results of the Clinical Efficacy of Resistance Testing Trial

Scott A. Wegner, Mark R. Wallace, Naomi Aronson, +18

Clinical Infectious Diseases

Routine AccessHiv/aids CounsellingPt ArmHuman RetrovirusClinical Trials +14